MedAvail Holdings, Inc. (MDVLQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Aug 26, 2025
MedAvail Holdings Revenue
MedAvail Holdings had revenue of $405.00K in the quarter ending June 30, 2023, a decrease of -25.41%. This brings the company's revenue in the last twelve months to $43.33M, up 212.15% year-over-year. In the year 2022, MedAvail Holdings had annual revenue of $43.11M with 94.81% growth.
Revenue (ttm)
43.33M
Revenue Growth
+212.15%
P/S Ratio
n/a
Revenue / Employee
155.29K
Employees
279
Market Cap
161.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 43.11M | 20.98M | 94.81% |
| Dec 31, 2021 | 22.13M | 8.16M | 58.43% |
| Dec 31, 2020 | 13.97M | 10.20M | 270.41% |
| Dec 31, 2019 | 3.77M | -894.00K | -19.16% |
| Dec 31, 2018 | 4.67M | 1.32M | 39.55% |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |